C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

NCT02936479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Antibody Mediated Rejection of Kidney Transplant

Interventions

DRUG: C1-INH (Berinert)

Sponsor

NYU Langone Health

Collaborators

[object Object]